curriculum vitae maya campara, pharmd, … 2018 phar414 introduction to patient care “medication...

CAMPARA | February 2018

CURRICULUM VITAE MAYA CAMPARA, PHARMD, BCPS

PERSONAL INFORMATION

Office Address: Department of Pharmacy Practice University of Illinois College of Pharmacy 833 South Wood Street; Suite 164 Chicago, IL 60612-7230

Email: [email protected]

Office Phone: (312) 355-2213

LICENSURE AND CERTIFICATION

Licensure: Illinois Pharmacist (2006) Certification: American Pharmacists Association Immunization (2006)

Basic First Aid and Cardiopulmonary Resuscitation (2006 – 2014) Advanced Cardiac Life Support (2006 – 2014)

Board Certification: Board Certified Pharmacotherapy Specialist (2010, 2017) Other: National Provider Identifier (2010)

EDUCATION AND POST-GRADUATE TRAINING

1997-2002 Bachelor of Arts in French Language and Literature

Loyola University at Chicago, IL 1997-2002 Bachelor of Science in Chemistry

Loyola University at Chicago, IL 2002-2007 Doctor of Pharmacy

University of Illinois at Chicago, IL 2006-2007 ASHP Accredited Pharmacy Practice Residency

University of Illinois Hospital, Chicago, IL 2007-2008 ASHP Accredited Specialty Residency/Solid Organ Transplant

University of Illinois Hospital, Chicago, IL

PRESENT APPOINTMENT EFFORT: 5% Teaching (classroom lectures and recitations)

80% Patient Care (direct patient care and student/resident training) 5% Research and Scholarly Activity 5% Administration 5% Public and Professional Service

2 CAMPARA | February 2018

ACADEMIC APPOINTMENTS Jul 2006 – Jun 2008 Clinical Associate

Department of Pharmacy Practice, College of Pharmacy University of Illinois at Chicago, Chicago, Illinois

May 2009 – Present Clinical Assistant Professor

Department of Pharmacy Practice, College of Pharmacy University of Illinois at Chicago, Chicago, Illinois

May 2015 – Present External Examiner for the Master of Clinical Pharmacy Program

Department of Pharmacology and Pharmacy The University of Hong Kong; Li Ka Shing Faculty of Medicine Hong Kong, China

Nov 2016 – Present Adjunct Faculty

Department of Pharmacy Faculty of Medicine and Surgery Msida, Malta

Aug 2017 – Present Clinical Assistant Professor

Department of Surgery, College of Medicine University of Illinois at Chicago, Chicago, Illinois

PROFESSIONAL EXPERIENCE

Jun 2000 – Jun 2006 Walgreen’s Pharmacy Intern and Pharmacy Technician Jun 2003 – Jun 2006 Dominic’s/Safeway Pharmacy Intern and Pharmacy Technician Jul 2006 – Jun 2007 PGY1 Trainee Clinical Pharmacist

Clinical Pharmacist On-Call Adult/Pediatric Code Team and Stroke Team Pharmacist University of Illinois Hospital, Chicago, IL

Jul 2007 Pharmacy Resident On-Call Trainer

Department of Pharmacy Practice University of Illinois Hospital, Chicago, IL

Jul 2007 – Jun 2008 PGY2 Trainee Clinical Pharmacist, Solid Organ Transplant


Aug 2008 – Dec 2009 Clinical Pharmacist, Medication Therapy Management


Aug 2008 – Present Clinical Pharmacist, Solid Organ Transplant

Department of Pharmacy Practice University of Illinois Hospital, Chicago, IL Aug 2015 – Present Team Leader, Solid Organ Transplant Clinical Pharmacist Team



CLINICAL PRACTICE SITES

Aug 2008 – Dec 2009 Medication Therapy Management Clinic University of Illinois Hospital, Chicago, IL

• Patients with multiple chronic medications who are struggling with adherence; 1 half-day clinic; scheduled 4 patients per week Daily duties included:

• Motivational interviewing, adherence assessment • Patient education and counseling • Care coordination and documentation

Aug 2008 – Apr 2012 Fink Liver Center University of Illinois Hospital, Chicago, IL

• Liver recipient pre-transplant evaluation and post-transplant care (acute and chronic); 1 half-day clinic per week; scheduled 20 patients per week. Daily duties included:

• Patient assessment (medication reconciliation, adherence, review labs, perform pharmacist specific review of systems)

• Collaborative management (determining immunosuppression regimen, subsequent allograft function monitoring and immunosuppression adjustment, management of comorbidities and adverse events/toxicities)

• Patient education and counseling • Care coordination, documentation and billing

Aug 2008 – Present Transplant Center

University of Illinois Hospital, Chicago, IL • Kidney and pancreas recipient pre-transplant evaluation and

post-transplant care (acute and chronic); 8 half-day clinics per week; scheduled 110 patients per week. Daily duties include:

• Patient assessment (medication reconciliation, adherence, review labs, perform pharmacist specific review of systems)

• Per protocol management (determining immunosuppression regimen, subsequent allograft function monitoring and immunosuppression adjustment, management of comorbidities and adverse events/toxicities)

• Patient education and counseling • Care coordination, documentation and billing

Aug 2008 – Present Transplant Intensive Care Unit

University of Illinois Hospital, Chicago, IL • Kidney, liver, pancreas, small bowel and islet recipients and

living donors; 12-bed ICU and 10-bed step-down unit Daily duties include:

• Patient assessment (medication reconciliation, review labs, adherence)

• Per protocol management (immunosuppression selection, subsequent allograft function monitoring and immunosuppression adjustment, management of comorbidities and adverse events/toxicities)

• Patient education and counseling • Care coordination, documentation


DIDACTIC TEACHING EXPERIENCE

CLASS COORDINATOR

Spring 2013 – 2014 PMPR385 Advanced Transplant Therapeutics (Temporary) Third year pharmacy students

Spring 2015 – Present PMPR347 Advanced Transplant Therapeutics (Permanent)

Third year pharmacy students Fall 2017 – Present PHAR504 Pathophysiology, Drug Action, & Therapeutics 4 Second year pharmacy students

LECTURES/RECITATIONS Spring 2007 PMPR370 Grand Rounds

“Drug-induced liver disease,” 1-hour lecture First year pharmacy students (elective)

Spring 2008 PHAR407 Principles of Drug Action and Therapeutics VII

“Transplant therapeutics,” 3-hour lecture and 6-hour recitation Third year pharmacy students

Fall 2008 – Present PHAR371 Advanced Pharmacy Practice Experience - Am Care

“Morning Conference: anemias” 1-hour lecture 4 times per year Fourth year pharmacy students

Spring 2009 – 2011 PHAR407 Principles of Drug Action and Therapeutics VII

“Transplant therapeutics,” 6-hour recitation Third year pharmacy students

Fall 2009 – 2014 PMPR381 Chronic Kidney Disease

“Renal transplantation," 2-hour lecture Second year pharmacy students (elective)

Fall 2009 – 2016 PHAR333 Fundamentals of Drug Action III

“Activation of T and B cells,” 2-hour lecture “Cytokines,” 1-hour lecture Second year pharmacy students

Fall 2009 – 2011 Principle of Drug Action and Therapeutics I

“CKD anemia,” 6-hour recitation “CKD hyperparathyroidism,” 6-hour recitation Second year pharmacy students

Spring 2010 – 2016 PMPR440 Pharmacokinetics

“Clinically relevant drug interactions,” 2-hour lecture Third year pharmacy students (elective)



Fall 2012 – 2016 PHAR352 Experiential II

“Pharmacist specific review of systems,” 1-hour lecture Second year pharmacy students




Spring 2013 –2017 PMPR347 Advanced Transplant Therapeutics

“Pancreas and islet transplantation,” 2-hour lecture Third year pharmacy students (elective)

Spring 2014 – 2015 PHAR407 Principles of Drug Action and Therapeutics VII

“Transplant therapeutics,” 6-hour recitation Third year pharmacy students

Fall 2014 PHAR346 Pharmacy Services and Reimbursement

“A unique practice: solid organ transplant,” 1-hour lecture Second year pharmacy students



Fall 2016 PHAR333 Fundamentals of Drug Action III

“Tolerance & autoimmunity,” 1-hour lecture Second year pharmacy students

Fall 2016 PMPR381 Chronic Kidney Disease



“Transplant Therapeutics,” 6-hour recitation Third year pharmacy students

Fall 2017 PHAR504 Principles of Drug Action and Therapeutics IV

“Activation of T and B cells,” 2-hour lecture and 4-hour recitation “Cytokines,” 1-hour lecture “Tolerance & autoimmunity,” 1-hour lecture and 4-hour recitation “Transplant therapeutics,” 2-hour lecture and 4-hour recitation Second year pharmacy students

Fall 2017 PMPR381 Chronic Kidney Disease


Fall 2017 PHAR464 Patient Safety “Patient safety in the hospital,” 2-hour panel discussion Second year pharmacy students Spring 2018 PHAR414 Introduction to Patient Care

“Medication based review of systems and physical exam,” 1-hour lecture and 4-hour recitation

Second year pharmacy students

INDEPENDENT STUDY/SPECIAL PROJECTS

Fall 2010 – Present PMPR380; Undergraduate Research in Pharmacy Practice


First, second and third year pharmacy students Fall 2011 - 2015 PMPR390; Special Projects in Pharmacy Practice First, second and third year pharmacy students CLINICAL TEACHING EXPERIENCE

Fall 2008 – Present PHAR352; Experiential II (IPPE) First year pharmacy students, 1-week shadowing rotation

Fall 2008 – Present PHAR353; Experiential III (IPPE) Second year pharmacy students – patient interviews

Fall 2008 – Present ASHP Accredited Pharmacy Practice Residency Solid Organ Transplant Clinics, PGY1 Resident Preceptor

University of Illinois Hospital Chicago, IL PGY1 residents included: 1. Lynley Heinrich, 2008/2009 2. Lamies Abuakar, 2008/2009 3. Jamie Joseph, 2008/2009 4. Julie Justo, 2009/2010 5. Kelly Valla, 2009/2010 6. Melinda Soriano, 2010/2011 7. Krista Williams, 2010/2011 8. Sarah Kwasigroch, 2010/2011 9. Tatyana Lawrecki, 2010/2011 10. Katherine Jennings, 2011/2012 11. Shree Patel, 2011/2012 12. Rene Thomas, 2012/2013 13. Roseanne Patel, 2012/2013 14. Seema Patel, 2012/2013 15. Aileen Chu, 2012/2013 16. Laura Lourenco, 2013/2014 17. Laura Means, 2013/2014 18. Cassie Stromayer, 2014/2015 19. Amy Hilliard , 2014/2015 20. Kelly Burke, 2014/2015 21. Meghan Glynn, 2015/2016 22. John Lyons, 2015/2016 23. Kristin Progar, 2015/2016 24. Clare Kane, 2015/2016 25. Ashley Loethen, 2016/2017 26. Danielle Tompkins, 2016/2017 27. Melika Fini, 2017/2018 28. Jovan Borjan, 2017/2018

Fall 2008 – Present ASHP Accredited Specialty Residency/Solid Organ Transplant

Solid Organ Transplant Clinics, PGY2 Resident Preceptor University of Illinois Hospital, Chicago, IL PGY2 organ transplant residents included: 1. Erika Meredith, 2008/2009 2. Jamie Joseph, 2009/2010 3. Lynley Heinrich, 2010/2011 4. Tatyana Lawrecki, 2011/2012 5. Shree Patel, 2012/2013 6. Michelle Huber, 2013/2014


7. Kelly Galen, 2013/2014 8. Marissa Janusak, 2014/2015 9. Cassie Stromayer, 2015/2016 10. Natalia Jasiak, 2015/2017 11. Kristin Progar 2016/2017 12. Karen Khalil 2017/2018 13. Khushbu Tejani 2018/2019

Spring 2009 – Present PHAR354; Experiential IV (IPPE) Second year pharmacy students – patient interviews Summer 2009 – Present PHAR357; Experiential V (IPPE) Third year pharmacy students, 5-week rotation

1. Gary Peksa, Summer 2009 2. Stephanie Williams, Summer 2009 3. Salvador Gutierrez, Summer 2009 4. Pedro Abreu, Summer 2009 5. Ephrem Gebremedhin, Summer 2010 6. Rutu Joshi, Summer 2010 7. Richard Debartolo, Summer 2012 8. Bhanupriya Sirandas, Summer 2012 9. Rebecca Lee, Summer 2013 10. Masooma Razvi, Summer 2013 11. Alika Moitra, Summer 2014 12. Issia Judeh, Summer 2014 13. Samantha Kush, Summer 2015 14. Melissa Moriarty, Summer 2015 15. Rachael Freeman, Summer 2016 16. Kari Nishikawa, Summer 2016 17. Sean Beirne, Summer 2017

Fall 2009 – Present PHAR371; APPE – Ambulatory Care Fourth year pharmacy students, 6-week rotation

1. Mary Hormese, Fall 2009 2. Monika Zbyszynska, Fall 2009 3. Michelle Bryson, Fall 2010 4. Nanette Gamazon, Fall 2010 5. Kathleen Sese, Fall 2010 6. Anna Portokalis, Fall 2010 7. Joshua Weith, Fall 2010 8. Chia Wei, Fall 2011 9. Nirmal Ghuman, Fall 2011 10. Naeil Elhaj, Fall 2012 11. Ho-Ting Chang, Fall 2012 12. Anuja Vallabh, Fall 2013 13. Loriel Solodokin, Fall 2013 14. Puay Hoon Lee, Spring 2013 15. Katherine Jahng, Fall 2014 16. Rekha Nair, Fall 2014 17. Vinay Soni, Spring 2014 18. John Donaldson, Fall 2015 19. Michelle Nguyen, Fall 2015 20. Jennifer Lee, Spring 2015 21. Michelle Kapugi, Fall 2016 22. Joshua Uvodich, Fall 2016 23. Sarah Chismark, Fall 2016


24. Rozhan Sadr, Fall 2017 25. Helen Sweiss, Fall 2017 26. Ali Alobaidi, Spring 2018

Fall 2012 – Present ASHP Accredited Ambulatory Care Pharmacy Residency

Solid Organ Transplant Clinics, PGY2 Resident Preceptor University of Illinois Hospital, Chicago, IL PGY2 ambulatory care residents included: 1. Annie Tran, 2013/2014 2. Shuba Bhat, 2013/2014 3. Carol Chan, 2016/2017 4. Kaitlyn Craddock, 2017/2018

Fall 2012 – Present UIC/Walgreen’s Community Pharmacy Residency

Solid Organ Transplant Clinics, PGY1 Resident Preceptor University of Illinois Hospital, Chicago, IL PGY1 community residents included: 1. Lisa Kumor, 2012/2013 2. Meghan Robbins, 2016/2017 3. Jelena Toro, 2017/2018

Fall 2013 ASHP Accredited Pharmacy Practice Residency

Solid Organ Transplant Intensive Care Unit, Preceptor Jesse Brown VA Medical Center, Chicago, IL 1. Bhanupriya Sirandas, 2013/2014

Spring 2018 – Present ASHP Accredited Pharmacy Practice Residency

Transplant Nephrology Inpatient Consult Service, Preceptor University of Illinois Hospital, Chicago, IL 1. Devon Burhoe, 2017/2018

INTERNATIONAL TEACHING EXPERIENCE

Spring 2009 – Present Visiting Pharmacist Program

Solid Organ Transplant Clinics, Preceptor University of Illinois Hospital, Chicago, IL 1. Ms. Lee, Visiting Scholar from China; February – March 2009 2. Chien Chin Wu, Visiting Scholar from Taiwan; July – August 2009 3. Ms. Law, Visiting Scholar from Taiwan; September 2009 4. Chic-Hsun Tai, Visiting Scholar from Taiwan; September – October

2009 5. Mr. Edward, Visiting Scholar from Taiwan; March – April 2010 6. Weerachai Chaijamorn, Visiting Scholar from Thailand; June –

August 2010. 7. Ms. Imel, Visiting Scholar from Singapore; October 2010 8. Melissa Ngai, Visiting Scholar from Singapore; October – November

2010 9. Mei-Hsin Lin, Visiting Scholar from Taiwan; October – November

2010 10. Jonathan Seah, Visiting Scholar from Singapore; November –

December 2010 11. Ms. Daraporn, Visiting Scholar from Singapore; July – August 2011 12. Jun Li, Visiting Scholar from China; May – June 2012 13. Qin Li, Visiting Scholar from China; May – June 2012 14. Zhijun Liu, Visiting Scholar from China; May – June 2012


15. Chunlai Ma, Visiting Scholar from China; May – June 2012 16. Zhengzheng Xie, Visiting Scholar from China; May – June 2012 17. Ma Zhu, Visiting Scholar from China; May – June 2012 18. Helen Wu, Visiting Scholar from China; April – June 2013 19. Dasheng Sang, Visiting Scholar from China; April – June 2013 20. Ms. Stephane, Visiting Scholar from Italy; January 2014 21. Yun-Ting Peng, Visiting Scholar from Taiwan; April 2015 22. Xandra Garcia Gonzalez, Visiting Scholar from Spain; April – May

2015 23. Kamonwan Onlamai, Visiting Scholar from Thailand; September

2015 24. Xiaoyu Qui, Visiting Scholar from China; November – December

2015 25. Phakapan Bowornkasinthum, Visiting Scholar from Thailand;

October 2016 26. Wilaiwan Rojkulpanichakul, Visiting Scholar from Thailand; October

2016 27. Yan Yang, Visiting Scholar from China; October – November 2016 28. Rou Wei Lim, Visiting Scholar from Singapore; January – February

2017 29. Shanshan Cao from China; May – June 2017 30. Cherie Lucas, Ph.D., Sydney, Australia – July 2017 31. Kylie Williams, Ph.D., Sydney, Australia – July 2017 32. Yu (Tempo) Heng, Visiting Scholar from China; October 2017 33. Li F. Yang, Visiting Scholar from China, November 2017 34. Ashley (Huang Kuei-Jung) from China, March 2018 35. Patty (Chen Feng-Ju) from China, April 2018 36. Tarin (Lin Tien-Jui) from China, April 2018

Fall 2016 Principles of Drug Action and Therapeutics

“Transplant therapeutics,” 4-hour lecture and 3-hour recitation International pharmacy students, Malta Program

COMMITTEE WORK

COLLEGE OF PHARMACY

2011 Careers in Pharmacy, Panel Discussion Member 2012 – 2013 Admission Committee; Multiple Mini Interview Team Member 2012 – Present Curricular Revision Steering Committee (Prerequisites/PDAT IV), Member 2013 – 2014 Accreditation Standards Review Subcommittee, Member 2013 – 2014 Student Faculty Relationship Committee, Faculty Representative 2016 – Present Student chapter ACCP/ISHP Clinical Case Series, Faculty Member 2016 – Present New Curriculum Implementation Subcommittee, Member 2017 – Present Kappa Psi Chi 2017 Scholarship Award Committee, Chair

DEPARTMENT OF PHARMACY PRACTICE

2009, 2016, 2017 Transplant Clinical Pharmacist Search Committee, Member 2009 – Present PGY1 Research Project Advisor 2009 – Present PGY1 Research Committee, Member 2013 – Present PGY1 Seminar Advisor

UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES

2008 – Present Organ Transplant Listing Committee, Member


2008 – Present Transplant Immunosuppression Guideline Review Committee, Member 2008-2015, Chair 2015 – Present

2009 – Present Solid Organ Transplant QI/Adverse Event Committee, Member 2010 – Present Data Monitoring Committee; Islet Transplantation, Member 2013 – Present Pancreas Transplant Quality Improvement Committee,

Member/Project Lead 2013 – Present Transplant Multidisciplinary Planning Committee, Member 2013 – Present Transplant Nephrology Fellow Search Committee, Member 2014 – 2016 Pain Committee, Member 2014 – Present Kidney Transplant Quality Improvement Committee, Member/Project Lead 2014 – Present University of Illinois Hospital Transplant Graft Failure Committee, Member 2015 Transplant Nurse Practitioner Search Committee, Member 2015 – 2016 Kidney Transplant Systems Improvement Agreement Committee, Member 2015 – 2016 Transplant Team Conference (weekly), Coordinator 2015 – Present Small Bowel Transplant Quality Improvement Committee, Member 2016 Optimizing the Provider Team Work Group, Member 2016 – Present Transplant Operational Committee, Member 2016 – 2017 Transplant Team Seminar Series (weekly), Coordinator 2016 – Present TransChart: Steering Committee, Member

PUBLICATIONS ARTICLES IN REFEREED JOURNALS Campara M, Ommert T, Thielke J, West Thielke P, Oberholzer J, Benedetti E and Kaplan B. ABO incompatible renal transplantation in an HIV-seropositive patient. Transplantation. 2008;86(1):176-178. Campara M, Shord S and Haaf CM. Retrospective analysis of rasburicase use in adult cancer patients with tumor lysis syndrome associated hyperuricemia. J Clin Pharm Ther. 2009;34(2):207-13. Campara M, Tzvetanov IG and Oberholzer J. Interleukin-2 receptor blockade with humanized monoclonal antibody for solid organ transplantation. Expert Opin Biol Ther. 2010;10(6):959-69. Rodriguez M, Campara M and Haaf C. Rasburicase in cancer-related hyperuricemia. Drugs Today (Barc). 2011;47(8):591-603. Reid G, Grim SA, Layden JE, Akkina S, Tang I, Campara M and Clark N. The use of fosfomycin to treat urinary tract infections in kidney transplant recipients. Transplantation. 2013;96(3):e12-4. Maldonado AQ, Tichy EM, Rogers CC, Campara M, Ensor C, Doligalski CT, Gabardi S, Descourouez JL, Doyle IC and Trofe-Clark J. Assessing pharmacologic and nonpharmacologic risks in candidates for kidney transplantation. Am J Health Syst Pharm. 2015;72(10):781-93. Garcia-Roca R, Garcia-Aroz S, Tzvetanov IG, Giulianotti PC, Campara M, Oberholzer J, Benedetti E. Simultaneous living donor kidney and parathyroid allotransplantation: first case report and review of literature. Transplantation. 2016;100(6):1318-21. Lee B, Petzel-Gimbar R, Campara M. Random tacrolimus levels in the emergency department - practice alert. Am J Health Syst Pharm. 2016;73(17):1297-8. Spaggiari M, Bissing M, Campara M, Yeh CC, Tzvetanov I, Jeon H, Benedetti E. Pancreas transplantation from pediatric donors: a UNOS registry analysis. Transplantation. 2017 Oct;101(10):2484-2491.


West-Thielke P, Progar K, Campara M, Jasiak N, Gallon L, Tang I, Spaggiari M, Tzvetanov IG, Benedetti E. Eculizumab for prevention of antibody mediated rejection in blood group incompatible renal transplantation. Transplant Proceedings.2018;50(1):66-69. Spaggiari M, Di Bella C, Di Cocco P, Campara M, Galen K, Gheza F, Oberholzer J, Benedetti E, Tzvetanov I. Pancreas Transplantation from pediatric donors: a single center experience. Transplantation. 2018; TBD. MANUSCRIPTS PENDING PUBLICATION IN REFEREED JOURNALS Spaggiari M, Oberholzer J, Li Y, Danielson K, Campara M, Yeh CC, Mendoza-Elias J, Kaplan B, Benedetti E, Tzvetanov I. Kidney donation from obese kidney living donor: Donor and Recipients outcomes from the UNOS registry. Submitted to JAMA on June 16, 2017; rejected. Submitted to AJT July 12, 2017; rejected. Submitted to Transplantation September 15, 2017; rejected. Submitted to Transplant International January 2018. BOOK CHAPTERS Campara M and Porter A. Pheochromocytoma. The 5-Minute Clinical Consult, 21st edition. Ed. Domino FJ. Philadelphia: Lippincott Williams & Wilkins, 2013. 988-989. Print, online, mobile. Campara M and Porter A. Pheochromocytoma. The 5-Minute Clinical Consult, 22nd edition. Ed. Domino FJ. Philadelphia: Lippincott Williams & Wilkins, 2014. 930-931. Print, online, mobile. Campara M and Porter A. Pheochromocytoma. The 5-Minute Clinical Consult, 23rd edition. Ed. Domino FJ. Philadelphia: Lippincott Williams & Wilkins, 2015. 912-913. Print, online, mobile. Campara M and Porter A. Pheochromocytoma. The 5-Minute Clinical Consult, 24th edition. Ed. Domino FJ. Philadelphia: Lippincott Williams & Wilkins, 2016. 850-851. Print, online, mobile. Campara M and Porter A. Pheochromocytoma. The 5-Minute Clinical Consult, 25th edition. Ed. Domino FJ. Philadelphia: Lippincott Williams & Wilkins, 2017. Online, mobile. Campara M and Porter A. Pheochromocytoma. The 5-Minute Clinical Consult, 26th edition. Ed. Domino FJ. Philadelphia: Lippincott Williams & Wilkins, 2018. Print, online, mobile. Campara M and Porter A. Pheochromocytoma. The 5-Minute Clinical Consult, 27th edition. Ed. Domino FJ. Philadelphia: Lippincott Williams & Wilkins, 2019. Print, online, mobile. OTHER WORKS Content Developer and Editor. Community Pharmacist Adherence Program. Pain education module and cases. September 2009. Content Developer and Editor. Community Pharmacist Adherence Program. Seizure education module and cases. September 2009. Content Developer and Editor. Counseling and management strategies for the organ transplant patients on maintenance immunosuppression. American Pharmacists Association Highlights Newsletter (Supplement to Pharmacy Today). November 2009;12(3)1-8. Transplant Pharmacotherapy Team. University of Illinois at Chicago Department of Pharmacy Practice annual report. April 2015. Content Developer and Editor. University of Illinois Hospital G-18.10 Immunosuppression and prophylaxis guidelines for solid organ transplant. November 2015.


Content Developer and Editor. University of Illinois Hospital P-13.14 Pharmacy transplant medication therapy management protocol. November 2015. Transplant Pharmacotherapy Team. University of Illinois at Chicago Department of Pharmacy Practice annual report. April 2016. Content Developer and Editor. UIH Transplant Team: Guideline for the multidisciplinary adherence assessment and evaluation of transplant candidates. September 2016. Illinois Transplant Pharmacists Association in the spotlight. American Society of Transplantation Transplant Pharmacy Community of Practice website. October 2016. Content Developer and Editor. UIH Transplant Team: Clinical care pathway for kidney allograft recipients. May 2017. INVITED PRESENTATIONS INTERNATIONAL April 2012 “Teaching pharmacotherapy and clinical skills effectively” 2-Day Education Workshop presented to pharmacists National Taiwan University Hospital, Taipei, Taiwan March 2016 “Transplant therapeutics: liver and heart transplantation” 3-Day Clinical Education Workshop presented to pharmacists ACCP Pharmacotherapy and Clinical Practice Series, Manila, Philippines March 2016 “Transplant therapeutics: renal transplantation” 3-Day Clinical Workshop presented to pharmacists ACCP Pharmacotherapy and Clinical Practice Series, Manila, Philippines March 2016 “Transplant therapeutics: immunology and pharmacotherapy” 3-Day Clinical Workshop presented to pharmacists ACCP Pharmacotherapy and Clinical Practice Series, Manila, Philippines January 2017 “Immunosuppression therapeutics – desensitization and induction” Nephrology Fellows Webinar Series Nephrology Division, Instituto Nacional de Cardiología, Ignacio Chávez Mexico City, Mexico February 2017 “Immunosuppression therapeutics – maintenance and rejection, part 1” Nephrology Fellows Webinar Series Nephrology Division, Instituto Nacional de Cardiología, Ignacio Chávez Mexico City, Mexico March 2017 “Immunosuppression therapeutics – maintenance and rejection, part 2” Nephrology Fellows Webinar Series Nephrology Division, Instituto Nacional de Cardiología, Ignacio Chávez Mexico City, Mexico September 2018 “Belatacept – a novel approach to improve recipient and allograft outcomes” Transplant Nursing Symposium International Transplant Nurses Society Rosemont, IL, USA


NATIONAL April 2007 “Recombinant urate oxidase for tumor lysis syndrome”

Great Lakes Pharmacy Resident Research Conference; Lafayette, IN ACPE accredited CE program equivalent to 0.5 contact hours.

April 2008 “Mycophenolate dose manipulation – does it make a difference?” Great Lakes Pharmacy Resident Research Conference; Lafayette, IN ACPE accredited CE program equivalent to 0.5 contact hours. April 2009 “Counseling and management of transplant patients” American Pharmacist Association Annual Meeting; San Antonio, TX ACPE accredited CE program equivalent to 1.0 contact hours March 2011 “Meeting the needs of transplant recipients in community pharmacies” American Pharmacist Association Annual Meeting; Seattle, WA. ACPE accredited CE program equivalent to 1.0 contact hours November 2013 “Improving adherence through multidisciplinary collaboration” North American Liver Transplant Social Workers Conference, Chicago, IL October 2014 “Billing for services: transplant PharmD” American College of Clinical Pharmacy Annual Meeting; Austin, TX

ACPE accredited CE program equivalent to 0.5 contact hours. July 2015 “Outpatient transplant pharmacist roles: MTM and transitions of care” ACCP Immunology/Transplantation PRN Webinar, Chicago, IL June 2016 “Successfully billing for pharmacist services in the ambulatory setting: effective

strategies for a hospital based practice setting” American Transplant Congress; Boston, MA

ACPE accredited CE program equivalent to 1.o contact hours. November 2016 “Transplant pharmacist primer for PharmD students” ACCP Immunology/Transplantation PRN Webinar December 2016 “Financial challenges surrounding SOT”, Moderator ACCP Immunology/Transplantation PRN Webinar

ACPE accredited CE program equivalent to 1.0 contact hours. May 2017 “Optimizing pharmacologic risk assessment of transplant recipients and living

donors”, Moderator American Transplant Congress; Chicago, IL

ACPE accredited CE program equivalent to 1.0 contact hours. October 2017 “Solid Organ Transplantation in HIV or HCV-Infected Recipients: Controversies in

Patient Management”, Moderator American College of Clinical Pharmacy Annual Meeting; Phoenix, AZ

ACPE accredited CE program equivalent to 1.0 contact hours. June 2018 “Assessing and Addressing Medication Non-Adherence in the “Real World”

Clinical Setting”, Moderator American Transplant Congress; Seattle, WA.

ACPE accredited CE program equivalent to 1.0 contact hours. LOCAL


October 2006 “Hepatorenal syndrome” University of Illinois Medical Center at Chicago; Chicago, IL

ACPE accredited CE program equivalent to 1.0 contact hour or 0.1 CEU. July 2007 “Recombinant urate oxidase for tumor lysis syndrome”

Illinois Council of Health-System Pharmacists Annual Meeting; Lincolnshire, IL ACPE accredited CE program equivalent to 0.5 contact hours.

September 2007 “Islet cell transplantation”

University of Illinois Medical Center at Chicago, Chicago, IL ACPE accredited CE program equivalent to 1.0 contact hour or 0.1 CEU.

December 2007 “Therapeutic monitoring of mycophenolic acid – is there clinical utility?”

Illinois Transplant Pharmacists Association; Chicago, IL March 2008 “African American kidney transplants & “early” steroid withdrawal?”

Illinois Transplant Pharmacists Association; Chicago, IL April 2008 “Mycophenolate dose manipulation – does it make a difference?” Illinois Transplant Pharmacists Association; Chicago, IL June 2011 “Immunosuppression after transplantation” 4th Annual UIC Transplant Conference, Chicago, Illinois May 2012 “How to be an effective clinical educator” Residents Teaching Conference, University of Illinois at Chicago July 2013 “How to be an effective clinical educator” Residents Teaching Conference, University of Illinois at Chicago July 2013 “A unique practice: solid organ transplantation” Visiting Pharmacist Summer Program, University of Illinois at Chicago March 2014 “Immunosuppression therapeutics” Nephrology Fellows Conference, University of Illinois at Chicago March 2014 “Immunosuppression review” New Nurse Orientation – Transplantation, University of Illinois at Chicago May 2014 “Immunosuppression review – desensitization and induction” Nurses Week – Transplant ICU, University of Illinois at Chicago Accredited 1h program for CE in nursing July 2014 “Immunosuppression review – maintenance and rejection” Nurses Week – Transplant ICU, University of Illinois at Chicago Accredited 1h program for CE in nursing August 2014 “How to be an effective clinical educator” Residents Teaching Conference, University of Illinois at Chicago September 2014 “Billing for services: transplant PharmD” Illinois Transplant Pharmacists Association, Chicago, IL March 2015 “Solid organ transplant pharmacy services: billing and documentation” Illinois Council of Health-System Pharmacists Clinical Practitioner and


Researcher Network Program; Chicago, IL July 2015 “A unique practice: solid organ transplantation” Visiting Pharmacist Summer Program, University of Illinois at Chicago August 2015 “How to be an effective clinical educator” Residents Teaching Conference, University of Illinois at Chicago September 2015 “CNI nephrotoxicity in the age of extended-release tacrolimus” UIC Transplant Pathology Conference; Chicago, IL

Accredited CME program equivalent to 0.5 contact hours. September 2015 “Immunosuppressants and their use in UIH transplant protocols” Transplant RN Educational Conference, University of Illinois at Chicago Accredited 1h program for CE in nursing October 2015 “A unique practice: solid organ transplantation” Visiting Pharmacist Program, University of Illinois at Chicago April 2016 “Transplant therapeutics – a review” Transplant APN Educational Conference, University of Illinois at Chicago May 2016 “NAPLEX review – transplant therapeutics and clinical cases” UIC College of Pharmacy, 2016 PharmD Class May 2016 “Immunosuppression therapeutics” Nephrology Fellows Conference, University of Illinois at Chicago June 2016 “What I need to know about my medications after kidney transplant” 9th Annual UIC Transplant Conference, Chicago, Illinois July 2016 “Solid organ transplantation/cases” Visiting Pharmacist Summer Program, University of Illinois at Chicago August 2016 “How to be an effective clinical educator”

Residents Teaching Certificate Conference, University of Illinois at Chicago October 2016 “Data collection and management” Residents Research Committee Conference, University of Illinois at Chicago July 2017 “Solid organ transplantation – a unique practice” Visiting Pharmacist Summer Program, University of Illinois at Chicago August 2017 “How to be an effective clinical educator”

Residents Teaching Certificate Conference, University of Illinois at Chicago November 2017 “Assessing Pharmacologic and Nonpharmacologic Risks in Candidates for Kidney

Transplantation” Transplant ICU RN Colloquia, University of Illinois at Chicago Accredited 1h program for CE in nursing January 2018 “Immunosuppression Review” Transplant RN Grand Rounds, University of Illinois at Chicago Accredited 1h program for CE in nursing


June 2018 “Your Partner in Longer Term Adherence Monitoring and Management – Transplant Pharmacist Services at UIC”

11th Annual UIC Transplant Conference, Chicago, Illinois Accredited 1h program for CE in nursing MENTORING/ADVISING PGY SEMINAR MENTOR; ACPE accredited CE program equivalent to 1.0 contact hour or 0.1 CEU. October 2013 “Acthar use in renal transplantation” PGY1 Laura Lourenco University of Illinois Hospital; Chicago, IL October 2013 “mTOR inhibitors after liver transplantation – a friend or a foe?” PGY1 Anela Ribo University of Illinois Hospital; Chicago, IL September 2014 “Tacrolimus dosage forms: QD vs. BID?” PGY1 Amy Hilliard University of Illinois Hospital; Chicago, IL October 2014 “Eculizumab for prevention of atypical hemolytic uremic syndrome in renal

transplantation” PGY1 Cassie Stromayer University of Illinois Hospital; Chicago, IL September 2015 “Hepatorenal Syndrome: Terlipressin Review” PGY1 John Lyons University of Illinois Hospital; Chicago, IL October 2015 “LCP-tacrolimus (Envarsus XR): Is it Worth the Wait?” PGY1 Kristin Progar University of Illinois Hospital; Chicago, IL October 2016 “CNI avoidance using mTOR inhibitor” PGY1 Jamie Micheletto University of Illinois Hospital; Chicago, IL November 2016 “The controversial truths behind vaccination in transplant patients” PGY1 Meghan Robbins University of Illinois Hospital; Chicago, IL January 2017 “Implications of marijuana use in solid organ transplant recipients” PGY2 Karen Khalil University of Illinois Hospital, Chicago, IL RESEARCH ACTIVITIES ORAL ABSTRACTS Walczak D, Campara M, Oberholzer J, Benedetti E. Minimal impact of substance abuse on long term kidney transplant outcomes. Am J Transplant. 2011;11s3:84 (#180). Presented at the American Transplant Congress, Philadelphia, PA. April 2011.


Tzvetanov I, Oberholzer J, Spaggiari M, Jeon H, Garcia-Roca R, Campara M, Thielke J, Giulianotti PC and Benedetti E. Robotic kidney transplantation in obese recipients: preliminary experience. Am J Transplant. 2012;12s3:72 (#157). Presented at the American Transplant Congress, Boston, MA. May 2012. POSTER ABSTRACTS

Fotis M, Campara M, Budris W. Recombinant factor VIIa is a useful tracer to identify serious adverse drug reactions to anticoagulants. Presented at the 41st Midyear Meeting of the American Society of Health-System Pharmacists, Orlando, CA. December 2006. Campara M, Shord S, Mactal Haaf C. Retrospective analysis of weight-based dosing of rasburicase in adult cancer patients with tumor lysis syndrome associated hyperuricemia. Presented at the 41st Midyear Meeting of the American Society of Health-System Pharmacists, Orlando, CA. December 2006. Walczak D, Tang I, Walczak D, McClure E, Campara M, Oberholzer J, Benedetti E, Kaplan B. Five year analysis of early steroid withdrawal in African American renal transplant recipients. Am J Transplant. 2008;8:587 (#1544). Presented at the American Transplant Congress – Award Winning Poster, Toronto, ON. June 2008. Oberholzer J, Campara M, West-Thielke P, Thielke J, Ommert T, Benedetti E, Kaplan B. ABO Incompatible renal transplantation in a HIV patient. Transplantation. 2008;86:585 (#1768). Presented at the 22nd International Congress of the Transplantation Society, Sydney, Australia. August 2008. Oberholzer J, Campara M, Thielke J, Ommert T, Herren H, West-Thielke P, Benedetti E, Kaplan B. Does dosing of mycophenolate mofetil 500 mg QID vs. 1000 mg BID impact efficacy and tolerability after renal transplantation. Transplantation. 2008;86:333 (# 961). Presented at the 22nd International Congress of the Transplantation Society, Sydney, Australia. August 2008. West-Thielke P, Campara M, Herren H, Thielke J, Tang I, Oberholzer J, Benedetti E, Kaplan B. BK viremia in positive cross match compared to negative cross match patients. Am J Transplant. 2009;9:423 (#805) Presented at the American Transplant Congress, Boston, MA. June 2009. Campara M, Thielke J, West-Thielke P, Herren H, Ommert T, Tang I, Oberholzer J, Benedetti E, Kaplan B. Does split dosing of mycophenolate mofetil (MMF) impact efficacy after renal transplantation? Am J Transplant. 2009;9:432 (#835). Presented at the American Transplant Congress, Boston, MA. June 2009. Campara M, Tzvetanov I, West-Thielke P, Tang I, Oberholzer J, Benedetti E. Impact of race on BK viremia after renal transplantation. Am J Transplant. 2010;10:329 (#999). Presented at the American Transplant Congress, San Diego, CA. May 2010. Walczak D, Campara M, Walczak D, McClure E, Oberholzer J, Akkina S, Tang I, Benedetti E. Effect of obesity on the outcomes of ABO incompatible and positive crossmatch kidney transplants. Am J Transplant. 2010;10:437 (#1393). Presented at the American Transplant Congress, San Diego, CA. May 2010. Akkina S, Campara M, Anattiwong P, Oberholzer J, Benedetti E, Lau A, Tang I. Effectiveness of vitamin D repletion in the correction of persistent secondary hyperparathyroidism in kidney transplant recipients. Am J Transplant. 2010;10:518 (#1691). Presented at the American Transplant Congress, San Diego, CA. May 2010. Anattiwong P, Campara M, Lau A, Walczak D, McClure E, Oberholzer J, Benedetti E, Akkina S, Tang I. Vitamin D status in new kidney transplant recipients in a multi-ethnic post-transplant clinic. Am J Transplant. 2010;10:519 (#1692). Presented at the American Transplant Congress, San Diego, CA. May 2010. Tang I, Akkina S, Campara M, Anattiwong P, Oberholzer J, Benedetti E, Lau A. Vitamin D status of long-term kidney transplant recipients in a multi-ethnic post-transplant clinic. Am J Transplant. 2010;10:519 (#1693). Presented at the American Transplant Congress, San Diego, CA. May 2010.


Campara M, Jeon H, Tzvetanov I, Oberholzer J, Benedetti E, Tang I. Renal allograft outcome in combined liver-kidney transplant (CLKT) on calcineurin inhibitor (CNI) vs. CNI and mycophenolate (M) maintenance immunosuppression. Am J Transplant. 2010;10:533 (#1744). Presented at the American Transplant Congress, San Diego, CA. May 2010. Akkina S, Anattiwong P, Campara M, Lau A, Tang I. Effective replacement of 25-OH vitamin D in kidney transplant recipients. Transplantation. 2010; 90:691. (#2496). Presented at the 24th International Congress of the Transplantation Society, Vancouver, Canada. August 2010. Akkina S, Anattiwong P, Campara M, Lau A, Tang I. Ergocalciferol treatment for 25-OH vitD deficiency does not increase rates of acute rejection. Transplantation. 2010;90:692. (#2527). Presented at the 24th International Congress of the Transplantation Society, Vancouver, Canada. August 2010. Campara M, Jeon H, Tzvetanov I, Oberholzer J, Benedetti E, Tang I. Outcomes of combined liver-kidney transplant (CLKT) recipients on calcineurin inhibitor (CNI) vs. CNI and mycophenolate (MMF) maintenance immunosuppression. Transplantation. 2010;90:852 (#2376). Presented at the 24th International Congress of the Transplantation Society, Vancouver, Canada. August 2010. Reid G, Grim S, Layden J, Akkina S, Tang I, Adams W, Campara M, Janda W, Clark N. The use of fosfomycin to treat urinary tract infections in kidney transplant recipients. Am J Transplant. 2012;12s3:212 (#614). Presented at the American Transplant Congress, Boston, MA May 2012. Patel S, Joseph J, Akkina S, West-Thielke P, Thielke J, Campara M, Oberholzer J, Benedetti E. A single-center, retrospective evaluation of outcomes following positive crossmatch renal transplantation despite failure to convert to negative crossmatch after desensitization. Am J Transplant. 2012;12s3:231 (#686). Presented at the American Transplant Congress, Boston, MA. May 2012. Lawrecki T, Thielke J, Campara M, West-Thielke P, Oberholzer J. Pancreas transplant outcomes-a single center experience with steroid avoidance. Am J Transplant. 2012;12s3:266 (#804). Presented at the American Transplant Congress, Boston, MA. May 2012. Tzvetanov I, Spaggiari M, Jeon H, Garcia-Roca R, Campara M, Thielke J, Oberholzer J, Benedetti E. Simultaneous ABO incompatibility and positive crossmatch in kidney transplantation: our experience and review of literature. Am J Transplant. 2012;12s3:503 (#1621). Presented at the American Transplant Congress, Boston, MA. May 2012. Voss J, Campara M, Akkina S, Khan A, Oberholzer J, Benedetti E, Tzvetanov I. Outcomes of kidney donors receiving ketorolac versus non-ketorolac-based pain regimens. Am J Transplant. 2014;14s3:251 (#B823). Poster of distinction at the 2014 World Transplant Congress, San Francisco, CA. July 2014. Campara M, Tzvetanov I, Giulianotti P, Khan A, Garcia-Roca R, Jeon H, Holterman M, John E, Benedetti E. Living donor parathyroid allotransplantation. Am J Transplant. 2014;14s3:339 (#C1587). Poster of distinction at the 2014 World Transplant Congress, San Francisco, CA. July 2014. Patel K, Campara M, Moriarti M, Akkina S. Fenofibrate impact on graft function after renal transplantation – fact or fiction? Am J Transplant. 2014;14s3:528 (#B930). Presented at the 2014 World Transplant Congress, San Francisco, CA. July 2014. Galen K, West-Thielke P, Huber M, Hetterman E, Benken J, Campara M, Johnsen M, Satterlee M, Thielke J. A prospective, randomized study of levofloxacin prophylaxis for BK viremia in kidney transplant recipients. Am J Transplant. 2014;14s3:554 (#B1016). Presented at the 2014 World Transplant Congress, San Francisco, CA. July 2014. West-Thielke P, Campara M, Ladik A, Terranova E, Benedetti E, Thielke J. Outcomes of Hispanic kidney transplant recipients under a cyclosporine- versus tacrolimus-based immunosuppression regimen. Am J Transplant. 2015; 15s3:250 (#D1921). Presented at the 2015 American Transplant Congress, Philadelphia, PA. May 2015.


Campara M, Kucher O, Akkina S, Tang IYS. Does calcineurin inhibitor timing matter? Single center experience with en-bloc kidney transplantation. J Am Soc Nephrol. 2015;26:613A (FR-PO1062). Presented at the 2015 American Society of Nephrology Kidney Week, San Diego, CA. November 2015. West-Thielke P, Lasky A, Thielke J, Campara M, Benedetti E. Outcomes of Hispanic kidney transplant recipients under a cyclosporine versus tacrolimus-based immunosuppression protocol. Am J Transplant. 2016;16s3:543(#B134). Presented at the 2016 American Transplant Congress, Boston, MA. June 2016. Lee B, Jain D, Campara M. Are random tacrolimus levels in the emergency department costing you money? Am J Transplant. 2016;16s3:627(#C78). Presented at the 2016 American Transplant Congress, Boston, MA. June 2016. Nam H, Perni N, Galen K, Campara M, Roca-Garcia R, Yeldandi V. Significance of preservation fluid cultures in solid organ transplantation. Am J Transplant. 2016;16s3:739(#D127). Presented at the 2016 American Transplant Congress, Boston, MA. June 2016. Valdepenas B, Virani A, Campara M. The impact of opioid-minimization using a ketorolac-based pain protocol following laparoscopic living donor nephrectomy. Presented at the American College of Clinical Pharmacy Annual Meeting, Hollywood, FL. October 2016. Martin MT, Rosenfeld D, Go GE, Lee T, Campara M, Tang IYS. Effectiveness of direct-acting antivirals in hepatitis C infected post-kidney transplant recipients. J Am Soc Nephrol. 2016;27:273A(TH-PO778). Presented at the 2016 American Society of Nephrology Kidney Week, Chicago, IL. November 2016. Campara M, Valdepenas B, Virani A, Tang I, Oberholzer J, Benedetti E. Obese kidney donors: impact of opioid-minimization using a ketorolac-based pain management protocol following robotically assisted, laparoscopic living donor nephrectomy. Presented at the 2017 American Transplant Congress, Chicago, IL. May 2017. Chan C, Tang I, Oberholzer J, Campara M. Outcomes following solitary pancreas transplantation – do steroids matter? Presented at the 2017 American Transplant Congress, Chicago, IL. May 2017. Horn K, Campara M, Martin M, Tang I. Effectiveness of direct-acting antiviral regimens in the treatment of hepatitis C virus (HCV) in kidney transplant recipients. J Am Soc Nephrol. 2017;28:497A(SA-PO497). Presented at the 2017 American Society of Nephrology Kidney Week, New Orleans, LA. November 2017. West-Thielke P, Campara M, Tang I, Benedetti E. Outcomes of Hispanic Kidney Transplant Recipients under a Cyclosporine versus Tacrolimus Based Immunosuppression Protocol. Am J Transplant. 2018; TBD(#D155). Presented at the 2018 American Transplant Congress, Seatle, WA. June 2018. Campara M, West-Thielke P, Progar K, Jasiak N, Lichvar A, Tang I, Benedetti E. Infectious Complications Associated with Eculizumab Used for ABO-Incompatible Renal Transplantation. Am J Transplant. 2018; TBD(#D165). Presented at the 2018 American Transplant Congress, Seatle, WA. June 2018. PHARMACY RESIDENT RESEARCH ABSTRACTS Drasga C, Tang I, Campara M. Recurrent urinary tract infections post renal transplant: what are the risk factors? Presented at the 44th Midyear Meeting of the American Society of Health-System Pharmacists, Las Vegas, NV. December 2009. Pangrazzi M, Akkina S, Benedetti E, Campara M. Infectious outcomes of interleukin-2 receptor antagonists used for maintenance immunosuppression in transplant patients. Presented at the 45th Midyear Meeting of the American Society of Health-System Pharmacists, Anaheim, CA. December 2010.


Lawrecki T, Thielke J, Campara M, West-Thielke P, Oberholzer J. Pancreas transplant outcomes - a single center experience with steroid avoidance. Presented at the 45th Midyear Meeting of the American Society of Health-System Pharmacists, Anaheim, CA. December 2010. Kusaka M, Campara M. Use of lymphocyte depleting vs. non-depleting induction therapy in liver transplantation – a single center experience. Presented at the 46th Midyear Meeting of the American Society of Health-System Pharmacists, New Orleans, LA. December 2011. Lawrecki T, West-Thielke P, Thielke J, Campara M, Cavallari L, Oberholzer J. Pharmacogenetic impact of UDP-glucuronosyltransferase metabolism of mycophenolic acid on clinical outcomes in renal transplant recipients. Presented at the University Health-System Consortium Annual Conference, New Orleans, LA. December 2011. Ribo A, Akkina S, Campara M. Assessment of risk factors for post-transplant diabetes mellitus in a racially diverse kidney transplant recipient population. Presented at the 47th Midyear Meeting of the American Society of Health-System Pharmacists, Las Vegas, NV. December 2012. Voss J, Akkina S, Campara M. Outcomes of kidney donors receiving ketorolac versus non-ketorolac based pain regimens. Presented at the 47th Midyear Meeting of the American Society of Health-System Pharmacists, Las Vegas, NV. December 2012. Kane C, Campara M. Sirolimus use to prevent the recurrence of hepatocellular carcinoma after liver transplantation. Presented at the 49th Midyear Meeting of the American Society of Health-System Pharmacists, Anaheim, CA. December 2014. Chin J, Campara M. Effect of ketorolac-based management of post-operative pain in living kidney donors. Presented at the 49th Midyear Meeting of the American Society of Health-System Pharmacists. Anaheim, CA. December 2014. Stromayer C, West-Thielke P, Campara M. An analysis of tacrolimus levels in African American kidney transplant recipients. Presented at the University Health-System Consortium Meeting. Anaheim, CA. December 2014. Wu YH, Campara M. Hydration protocol and early readmission rate in pancreas transplant. Presented at the 51st Midyear Meeting of the American Society of Health-System Pharmacists. Las Vegas, NV. December 2016. Chan C, Tang, I, Oberholzer J, Campara M. Readmission rates following pancreas transplantation – do steroids matter? Presented at the 51st Midyear Meeting of the American Society of Health-System Pharmacists. Las Vegas, NV. December 2016. Patel A., Campara M., Petzel-Gimbar R, Lichvar A. Examination of Complications Occurring Within One Year Post Renal Transplantation. Presented at the 52nd Midyear Meeting of the American Society of Health-System Pharmacists. Orlando, FL. December 2017. PHARMACY STUDENT RESEARCH ABSTRACTS Patel K, Campara M, Moriarti M, Akkina S. Fenofibrate impact on graft function after renal transplantation – fact or fiction? Pharmacotherapy. 2014:34(10):291e (422). Presented at the American College of Clinical Pharmacy Annual Meeting, Austin, TX. October 2014. Lee B, Jung I, Campara M. Random tacrolimus levels in the emergency department. Presented at the University of Illinois Hospital Annual Quality Fair, Chicago, IL. October 2015. Donaldson C, Wu D, Campara M. Intraoperative albumin avoidance in kidney transplantation. Presented at the University of Illinois Hospital Annual Quality Fair, Chicago, IL. October 2015.


Campara, M, Kucher O, Galen K, Akkina S, Tang I. Does timing of calcineurin inhibitor initiation matter? Single center experience with en-bloc kidney transplantation. Pharmacotherapy. 2015:35(11):320e (555). Presented at the Global Conference on Clinical Pharmacy, San Francisco, CA. October 2015 Valdepena B, Campara M. Kidney donor pain management – 1 year update. Presented at the University of Illinois Hospital Annual Quality Fair, Chicago, IL. October 2015. Lee B, Jung I, Campara M. Random TAC levels in the emergency department. Pharmacotherapy. 2015:35(11): 320e (556). Presented at the Global Conference on Clinical Pharmacy, San Francisco, CA. October 2015. Donaldson C, Kucher O, Galen K, Campara M. Role of interleukin-2 receptor antagonists in maintenance immunosuppression for kidney transplant patients: a single-center experience. Presented at the 50th Midyear Meeting of the American Society of Health-System Pharmacists, New Orleans, LA. December 2015. Nguyen M, Moriarty M, Chang K, Santore A, Campara M. Does split dosing of mycophenolic acid impact renal transplant outcomes? Presented at the 50th Midyear Meeting of the American Society of Health-System Pharmacists, New Orleans, LA. December 2015. Moriarty M, Nguyen M, Patel K, Campara M. Does depleting vs. non-depleting induction therapy impact outcomes of elderly kidney transplant recipients? Presented at the 50th Midyear Meeting of the American Society of Health-System Pharmacists, New Orleans, LA. December 2015. NON-FUNDED ONGOING RESEARCH 2010-Present Co-investigator

Analysis of risk factors for long term outcomes of kidney and/or SPK transplant recipients (OPTN) 2010-Present Co-investigator

Pancreas transplant outcomes: A single center experience with steroid avoidance 2010-Present Co-investigator

The effects of thymoglobulin on immune cell function 2011-Present Co-investigator

Randomized case-control trial about the impact of targeted physical activity and diet modification on obese kidney transplant recipients outcome

2011-Present Co-investigator

Predictors for successful desensitization in kidney transplant recipients undergoing positive crossmatch protocols

2012-Present Faculty sponsor

Outcomes of kidney donors receiving ketorolac versus non-ketorolac based pain regimens 2013-Present Co-investigator

A comparison of alemtuzumab and antithymocyte globulin induction in high-risk, non-sensitized renal transplant recipients


A randomized, open label, multicenter study of a belatacept-based early antithymocyte globulin induction compared to a tacrolimus-based early glucocorticoid withdrawal regimen with rabbit antithymocyte globulin induction in renal transplantation


A randomized, double-blind, placebo-controlled Phase 2 trial to cytomegalovirus (CMV)- seronegative kidney transplant recipients receiving an organ from a CMV-seropositive donor


2016-Present Research assistant

Elucidating differences in obese vs non-obese transplant recipients and donors: drivers behind increased complications in obese transplant patients

2016-Present Faculty sponsor

Hydration protocol and early readmission rates in pancreas transplant

2016-Present Co-investigator Expanded access protocol for the treatment use of HBOC-201 (Hemopure) in patients with life threatening anemia, for whom blood is not an option

2017 – Present Faculty sponsor Emergency department visits after transplantation – are they a predictor of poor outcome

following renal transplantation 2017 – Present Co-investigator Prospective observational study of HIV+ deceased donor transplant for HIV+ recipients COMPLETED RESEARCH 2006-2008 Co-investigator

Assessment of oral loading of EC-MPS in African American renal transplant recipients undergoing rapid steroid elimination

2006-2008 Co-investigator Retrospective analysis of weight based dosing of rasburicase in adult cancer patients with tumor lysis syndrome associated hyperuricemia

2007-2009 Co-investigator

Retrospective/prospective study of kidney transplant outcomes January 1968 through present: patients transplanted prior to January 2007


CTOT-02: B-cell depletion by anti-CD20 (rituximab) in renal allograft recipients who develop de novo anti-HLA alloantibodies


A Phase 2, randomized, open-label, parallel group, multi-center study to assess the safety and efficacy of alefacept in de novo kidney transplant recipients


A Phase 2, open-label, multi-center, randomized trial to demonstrate the pharmacokinetics of LCP-Tacro tablets once daily and Prograf® capsules twice daily in adult de novo kidney transplant patients


A Phase 3, open-label, multicenter, prospective, randomized study of the efficacy and safety of conversion from Prograf capsules twice daily to LCP-TACRO tablets once daily for the prevention of acute allograft rejection in stable kidney transplant patients

2008-2014 Research assistant

Controlled, randomized, prospective, double-blind, multicenter, Phase I/II, dose-escalation study of the safety, PK, and clinical activity of l5NP for prophylaxis of delayed graft function in patients undergoing deceased donor kidney transplantation


2009-2010 Principal investigator Recurrent UTIs post renal transplant; what are the risk factors? 2009-2013 Co-investigator

A collaborative experience using bortezomib for the treatment of antibody-mediated rejection in solid organ transplantation


Levofloxacin prophylaxis for BK viremia in kidney transplant recipients 2010-2011 Faculty sponsor

Infectious outcomes of the use of interleukin-2 receptor antagonists (IL-2RAs) in maintenance 2010-2011 Principal investigator

Prevalence of vitamin D deficiency and secondary hyperparathyrodism after renal transplantation - What are the clinical implications


Retrospective study of measurement of standard liver volume in obese subjects without medical illness


A 12-month, multi-center, randomized, open-label non-inferiority study comparing the safety and efficacy of concentration-controlled everolimus with low dose tacrolimus to CellCept (mycophenolate mofetil) with standard dose tacrolimus in de novo renal transplant patients

2010-2012 Co-investigator A Phase lb, randomized, double-blind, parallel group, placebo-controlled, single-dose, pharmacokinetic, safety and tolerability study of ASKP1240 in de novo kidney transplantation

2011-2012 Faculty sponsor

Use of lymphocyte depleting vs. non-depleting induction therapy in liver transplantation - a single center experience

2011-2012 Principal investigator

Incidence of post-transplant diabetes in kidney transplant recipients 2011-2013 Co-investigator

Pharmacogenetic impact of UDP-glucuronosyltransferase metabolism of mycophenolic acid on clinical outcomes in renal transplant recipients


A randomized, open-label, multicenter trial to determine safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in living donor kidney transplant recipients requiring desensitization therapy study number: Cl0-001


Retrospective study about the role of splenectomy in the setting of refractory antibody mediated rejection after kidney transplantation


A Phase 3, double-blind, double-dummy, multi-center, prospective, randomized study of the efficacy and safety of LCP-Tacro tablets, once daily, compared to Prograf capsules, twice daily, in combination with mycophenolate mofetil for the prevention of acute allograft rejection in de novo adult kidney transplant recipients


2012-2014 Co-investigator A Phase 2, double-blind, double-dummy, multi-center, prospective, randomized study of the pharmacokinetics of LCP Tacro (TM) tablets, once daily, compared to Prograf(R) capsules, twice daily, for the prevention of acute allograft rejection in de novo adult kidney transplant recipients


Evaluating Nulojix long term safety in transplant (ENLiST) 2012-2014 Research assistant

LCP-Tacro 3003 switching STudy of kidney tRansplant pAtients with tremor to LCP-TacrO (STRATO)


A Phase 2a, randomized, open-label, active control, multi-center study to assess the efficacy and safety of ASKP1240 in de novo kidney transplant

2012-2015 Co-investigator An open-label, Phase 2 study in patients with renal allograft and polyoma BK viruria for the prevention of renal allograft BK viremia, BK nephropathy and renal allograft rejection


Racial profile of live kidney donations at the University of Illinois at Chicago Medical Center from January 1, 2007 to May 31, 2012


Limited access protocol for the use of oral cisapride in the treatment of refractory gastroesophageal reflux disease and other gastrointestinal motility disorders - CIS-USA-154


A Phase 2/3, double-blind, placebo-controlled, two-part study (part 1 open-label) to assess the safety, efficacy and pharmacokinetics of single intravenous doses of ASP8597 (Diannexin) in de novo kidney transplant recipients


Acthar rescue therapy for transplant glomerulopathy in kidney transplant recipients 2014-2015 Co-investigator

A prospective observational trial to evaluate the correlation of T-SPOT® response to CMV infection and T cell-mediated acute graft rejection: the PROTECT study


A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs. mycophenolate with standard calcineurin inhibitor in de novo renal transplantation- Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM) Protocol No. CRAD001A2433

2015 Principal investigator Survey of clinical practice guideline implementation for pneumococcal immunization in adults 2015-2016 Research associate

Recipients expanded access study for renal transplant patients with Envarsus XR: 3007 2015-2017 Research associate


A randomized, placebo-controlled, prospective, double-blind, multicenter Phase 2/3 study of the efficacy and safety of SANGUINATE ™ for reduction of delayed graft function in recipients of a donation after brain death kidney transplant

2016-2017 Co-investigator Astagraf XL® to understand the impact of immunosuppression on de novo DSA development and chronic immune activation in kidney transplantation (ASTOUND)

PROFESSIONAL ORGANIZATIONS 2002 – 2006 Illinois Council of Health-System Pharmacists (ICHP), Member 2002 – 2006 American Pharmacists Association (APhA), Member 2002 – 2006 UIC Health Professions Student Council (HPSC), Member

Vice President 2003-2004, President 2004-2005, Past-President 2005-2006 2003 – Present Kappa Psi Professional Fraternity, Member

Grand Council Deputy 2014 – Present 2004 – 2006 Phi Lambda Sigma (PLS) National Leadership Society, Member

PLS Delegate – 30th House of Delegates; Orlando, Florida 2004 – 2006 Academy of Managed Care Pharmacy (AMCP), Member 2004 – 2013 American Society of Health-System Pharmacists (ASHP), Member 2008 – Present Illinois Transplant Pharmacist Association (ITPA), Member

Vice President 2015-2016, President 2016-2017, Past-President 2017-2018 2009 – Present American Society of Transplantation (AST), Member Tran Pharm Community of Practice (COP), Member at Large 2017-2019

Tran Pharm COP Public Policy Workgroup, Member 2015-Present Tran Pharm COP Programming/Education Workgroup, Member 2017-Present Tran Pharm COP Online Community Workgroup, Member 2017-Present Tran Pharm COP Adherence Workgroup, Member 2017-Present 2010 – Present Rho Chi Pharmacy Honor Society, Faculty Member 2010 – Present American College of Clinical Pharmacy (ACCP), Member Immunology/Transplantation PRN Programming Committee, Chair 2017 Immunology/Transplantation PRN Nominations Committee, Member 2018 REFEREE ACTIVITIES 2009 American Journal of Transplantation, Invited Manuscript Reviewer 2009 APhA Highlights Newsletter; Editorial Advisory Panel Member 2010 – Present Transplantation, Invited Manuscript Reviewer 2014 – Present AST Tran Pharm COP, Pancreas and Islet Transplantation Database Editor 2015, 2017 AST Tran Pharm COP, Travel Award Reviewer 2016 ACCP Student Travel Award Reviewer 2016 ACCP BCPS Mock Exam, External Reviewer 2016 – Present Expert Opinion on Drug Metabolism and Toxicology, Invited Manuscript Reviewer 2016 – Present Transplantation Direct, Invited Manuscript Reviewer 2016 – Present American Journal of Health-System Pharmacists, Invited Manuscript Reviewer 2017 – Present ACCP Abstract Reviewer OTHER PROFESSIONAL SERVICE 2012 Pfizer Transplant PharmD Advisory Board Member 2015 Novartis Transplant PharmD Advisory Board Member 2015 – Present ACCP, 2017 Annual Meeting Committee Member 2015 – Present ACCP, Research Institute PBRN Community Advisory Panel Member 2016 – Present AST Tran Pharm COP, OPTN/UNOS Policy Public Comment, Response Writer


2016 – Present Board of Pharmacy Specialties (BPS) Solid Organ Transplantation Role Delineation Study Taskforce Member

2017 – Present BPS Solid Organ Transplantation Certification; Petition Development Group, ACCP Clinician Member

2017 AST adherence symposium: tackling medication non-adherence in organ transplantation, Invited Member

HONORS AND AWARDS 1997 Presidential Scholarship Recipient, Loyola University of Chicago 2002 Claudel Key Recipient, Loyola University Chicago 2004 Joseph A. Koren Memorial Scholarship, University of Illinois at Chicago 2005 Glenn Kraiss Leadership Scholarship, University of Illinois at Chicago 2006 Van Doren Scholar, University of Illinois at Chicago 2010 Preceptor of the Year Nominee, College of Pharmacy, Class of 2010 2010 Golden Apple Nominee, UIC College of Pharmacy, Class of 2010 2011 Caught in the Act Recognition for Excellent Service, UIC Transplant Team 2014 Poster of Distinction, 2014 World Transplant Congress, San Francisco, CA 2014 Poster of Distinction, 2014 World Transplant Congress, San Francisco, CA 2015 Preceptor of the Year Nominee, College of Pharmacy, Class of 2015 2015 University of Illinois Hospital Quality Project Poster Fare, Third Place Winner 2017 UIC Teaching Recognition Program Award VOLUNTEER ACTIVITIES 2002 SOS Kinderdorf Student Teacher – Sarajevo, Bosnia 2004 American Diabetes Association Health Fair 2004/2005 Illinois Council of Health-System Pharmacists/Illinois Pharmacist’s Association Legislative

Day Health Fair 2005 UIC National Women's Check Up Day Health Fair 2005 National Woman’s Heart Day Health Fair 2005/2006 Dominick’s Pharmacy Immunization Clinic 2006 University of Illinois Hospital National Smoke Out Day 2008/2009 University of Illinois Hospital Immunization Day, Faculty Volunteer 2013 – Present University of Illinois at Chicago, Annual Donor Awareness Challenge LANGUAGES Fluent in Serbian and Croatian Proficient in French Learning Spanish

curriculum vitae maya campara, pharmd, … 2018 phar414 introduction to patient care “medication...

Documents